Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01030523 · ClinicalTrials.gov registry record · NA
Short Implants - An Alternative to Bone Grafting?
A NA study, sponsored by Dentsply Sirona Implants and Consumables.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT01030523: Completed NA study, sponsored by Dentsply Sirona Implants and Consumables.
NCT01030523 is a NA study that has completed, run by Dentsply Sirona Implants and Consumables. The registered enrollment target is 101 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01030523, a NA study, has completed, sponsored by Dentsply Sirona Implants and Consumables.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
The study, with the ASTRA TECH Implant System, is comparing short implants (OsseoSpeed™) to standard length implants (OsseoSpeed™) in combination with bone grafting. The hypothesis is that the use of short implants in posterior maxilla with inadequate bone is as safe and predictable as placing standard length implants in combination with bone augmentation.
Primary Outcome
Any implant that is removed after implant placement will be considered a failure, whatever the reason for removal. Implant survival will be evaluated clinically and radiographically by counting the number of remaining implants. Implant survival rate will be calculated by dividing the number of non-failures by the number of installed implant.
Interventions
- DEVICE ASTRA TECH Implant System, OsseoSpeed™ 4.0 S (length: 6 mm)
- DEVICE ASTRA TECH Implant System, OsseoSpeed™ implants (lengths: 11, 13, 15 mm) in combination with bone grafting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2009-10 |
| Est. Completion | 2022-03-22 |
| Phase | NA |
What the finished NCT01030523 record still lists
NCT01030523 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which ASTRA TECH Implant System, OsseoSpeed™ 4.0 S (length: 6 mm) is the first listed.
NCT01030523 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01030523 about?
NCT01030523 is a clinical study titled "Short Implants - An Alternative to Bone Grafting?". The study, with the ASTRA TECH Implant System, is comparing short implants (OsseoSpeed™) to standard length implants (OsseoSpeed™) in combination with bone grafting. The hypothesis is that the use of short implants in posterior maxilla with inadequate bone is as safe and predictable as placing stand...
What is the current status of trial NCT01030523?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2009-10. Estimated completion is 2022-03-22.
What interventions are being tested in trial NCT01030523?
The interventions under investigation include: ASTRA TECH Implant System, OsseoSpeed™ 4.0 S (length: 6 mm) (DEVICE), ASTRA TECH Implant System, OsseoSpeed™ implants (lengths: 11, 13, 15 mm) in combination with bone grafting (DEVICE).
Who is sponsoring clinical trial NCT01030523?
This trial is sponsored by Dentsply Sirona Implants and Consumables, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01030523's enrollment target sits among peer trials
101 840th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia